123 related articles for article (PubMed ID: 22839105)
41. New purine analogues for the treatment of chronic B-cell malignancies.
Gribbin TE
Henry Ford Hosp Med J; 1991; 39(2):98-102. PubMed ID: 1679757
[TBL] [Abstract][Full Text] [Related]
42. Sensitivity of chronic lymphocytic leukemia cells to chemotherapeutic drugs ex vivo depends on expression status of cell surface receptors.
Shcherbina V; Gordiienko I; Shlapatska L; Ivanivska T; Sidorenko S
Exp Oncol; 2020 Mar; 42(1):16-24. PubMed ID: 32231196
[TBL] [Abstract][Full Text] [Related]
43. The Hsp90 inhibitor SNX-7081 synergizes with and restores sensitivity to fludarabine in chronic lymphocytic leukemia cells with lesions in the TP53 pathway: a potential treatment strategy for fludarabine refractory disease.
Best OG; Che Y; Singh N; Forsyth C; Christopherson RI; Mulligan SP
Leuk Lymphoma; 2012 Jul; 53(7):1367-75. PubMed ID: 22149137
[TBL] [Abstract][Full Text] [Related]
44. Mechanism of action of purine analogues in chronic lymphocytic leukaemia.
Pettitt AR
Br J Haematol; 2003 Jun; 121(5):692-702. PubMed ID: 12780783
[No Abstract] [Full Text] [Related]
45. Targeting DNA repair with aphidicolin sensitizes primary chronic lymphocytic leukemia cells to purine analogs.
Starczewska E; Beyaert M; Michaux L; Vekemans MC; Saussoy P; Bol V; Arana Echarri A; Smal C; Van Den Neste E; Bontemps F
Oncotarget; 2016 Jun; 7(25):38367-38379. PubMed ID: 27223263
[TBL] [Abstract][Full Text] [Related]
46. In vitro chemosensitivity of chronic lymphocytic leukaemia to purine analogues--correlation with clinical course.
Bromidge TJ; Turner DL; Howe DJ; Johnson SA; Rule SA
Leukemia; 1998 Aug; 12(8):1230-5. PubMed ID: 9697877
[TBL] [Abstract][Full Text] [Related]
47. The expression of inhibitor of bruton's tyrosine kinase gene is progressively up regulated in the clinical course of chronic lymphocytic leukaemia conferring resistance to apoptosis.
Albano F; Chiurazzi F; Mimmi S; Vecchio E; Pastore A; Cimmino C; Frieri C; Iaccino E; Pisano A; Golino G; Fiume G; Mallardo M; Scala G; Quinto I
Cell Death Dis; 2018 Jan; 9(1):13. PubMed ID: 29317636
[TBL] [Abstract][Full Text] [Related]
48. High activity and incomplete cross resistance of nucleoside analogues cladribine and fludarabine versus Ara-C on leukemic cells from patients with AML.
Löfgren C; Albertioni F; Paul C
Ther Drug Monit; 2005 Oct; 27(5):641-6. PubMed ID: 16175139
[TBL] [Abstract][Full Text] [Related]
49. Therapeutic potential of purine analogue combinations in the treatment of lymphoid malignancies.
Johnson SA; Thomas W
Hematol Oncol; 2000 Dec; 18(4):141-153. PubMed ID: 11135355
[TBL] [Abstract][Full Text] [Related]
50. Drug induction apoptosis assay as predictive value of chemotherapy response in patients with B-cell chronic lymphocytic leukemia.
Castejón R; Yebra M; Citores MJ; Villarreal M; García-Marco JA; Vargas JA
Leuk Lymphoma; 2009 Apr; 50(4):593-603. PubMed ID: 19373658
[TBL] [Abstract][Full Text] [Related]
51. Association of reactive oxygen species-mediated signal transduction with in vitro apoptosis sensitivity in chronic lymphocytic leukemia B cells.
Palazzo AL; Evensen E; Huang YW; Cesano A; Nolan GP; Fantl WJ
PLoS One; 2011; 6(10):e24592. PubMed ID: 22016760
[TBL] [Abstract][Full Text] [Related]
52. [Research advance on fludarabine resistance mechanisms in chronic lymphocytic leukemia cells].
Yao L; Xu W; Li JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):821-4. PubMed ID: 20561458
[TBL] [Abstract][Full Text] [Related]
53. Comparative effects of cladribine, fludarabine and pentostatin on nucleotide metabolism in T- and B-cell lines.
Wilson PK; Szabados E; Mulligan SP; Christopherson RI
Int J Biochem Cell Biol; 1998 Jul; 30(7):833-42. PubMed ID: 9722988
[TBL] [Abstract][Full Text] [Related]
54. Physical contact with endothelial cells through β1- and β2- integrins rescues chronic lymphocytic leukemia cells from spontaneous and drug-induced apoptosis and induces a peculiar gene expression profile in leukemic cells.
Maffei R; Fiorcari S; Bulgarelli J; Martinelli S; Castelli I; Deaglio S; Debbia G; Fontana M; Coluccio V; Bonacorsi G; Zucchini P; Narni F; Torelli G; Luppi M; Marasca R
Haematologica; 2012 Jun; 97(6):952-60. PubMed ID: 22207686
[TBL] [Abstract][Full Text] [Related]
55. Role of the STAT1 pathway in apoptosis induced by fludarabine and JAK kinase inhibitors in B-cell chronic lymphocytic leukemia.
Martinez-Lostao L; Briones J; Forné I; Martinez-Gallo M; Ferrer B; Sierra J; Rodriguez-Sanchez JL; Juarez C
Leuk Lymphoma; 2005 Mar; 46(3):435-42. PubMed ID: 15621835
[TBL] [Abstract][Full Text] [Related]
56. Apoptosis induction with three nucleoside analogs on freshly isolated B-chronic lymphocytic leukemia cells.
Zinzani PL; Tosi P; Visani G; Martinelli G; Farabegoli P; Buzzi M; Ottaviani E; Salvucci M; Bendandi M; Zaccaria A
Am J Hematol; 1994 Dec; 47(4):301-6. PubMed ID: 7977303
[TBL] [Abstract][Full Text] [Related]
57. Deoxyadenosine analogs induce programmed cell death in chronic lymphocytic leukemia cells by damaging the DNA and by directly affecting the mitochondria.
Genini D; Adachi S; Chao Q; Rose DW; Carrera CJ; Cottam HB; Carson DA; Leoni LM
Blood; 2000 Nov; 96(10):3537-43. PubMed ID: 11071652
[TBL] [Abstract][Full Text] [Related]
58. The newer purine analogs. Significant therapeutic advance in the management of lymphoid malignancies.
Saven A; Piro LD
Cancer; 1993 Dec; 72(11 Suppl):3470-83. PubMed ID: 7902205
[TBL] [Abstract][Full Text] [Related]
59. More on purine analog-induced apoptosis in B cell chronic lymphocytic leukemia.
Morabito F; Filangeri M; Sculli G; Oliva B
Leukemia; 1998 Apr; 12(4):633-5. PubMed ID: 9557625
[No Abstract] [Full Text] [Related]
60. Apoptotic gene expression under influence of fludarabine and cladribine in chronic lymphocytic leukemia-microarray study.
Franiak-Pietryga I; Sałagacka A; Maciejewski H; Błoński JZ; Borowiec M; Mirowski M; Robak T; Korycka-Wołowiec A
Pharmacol Rep; 2012; 64(2):412-20. PubMed ID: 22661193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]